Biotricity Inc. (BTCY) stock
BTCYOTCSurgical & Medical Instruments & ApparatusFiscal year ends March 31
$0.05+0.00 (+8.70%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Biotricity net income
Net income is the profit left for shareholders after every expense, interest and tax.
Biotricity's net income for the twelve months ending Jun 30, 2026 was -$2.69M. For fiscal 2026 it was -$2.40M. The highest annual figure on record is -$91.07K in fiscal 2014.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$2.40M | – |
| FY2025 | Mar 31, 2025 | -$8.42M | – |
| FY2024 | Mar 31, 2024 | -$14.09M | – |
| FY2023 | Mar 31, 2023 | -$18.66M | – |
| FY2022 | Mar 31, 2022 | -$29.13M | – |
| FY2021 | Mar 31, 2021 | -$15.49M | – |
| FY2020 | Mar 31, 2020 | -$11.07M | – |
| FY2019 | Mar 31, 2019 | -$8.59M | – |
| FY2018 | Mar 31, 2018 | -$8.62M | – |
| FY2014 | Aug 31, 2014 | -$91.07K | – |
Quarterly net income
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | -$959.47K | – |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | -$324.18K | – |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | -$717.07K | – |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | -$690.91K | – |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | -$671.98K | – |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | -$1.94M | – |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | -$1.23M | – |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | -$1.56M | – |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | -$3.69M | – |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | -$4.18M | – |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | -$2.81M | – |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | -$3.69M | – |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | -$3.41M | – |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | -$4.67M | – |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | -$4.52M | – |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | -$5.61M | – |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | -$7.11M | – |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | -$10.75M | – |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | -$5.66M | – |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | -$5.47M | – |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | -$3.90M | – |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | -$2.96M | – |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$3.16M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$4.60M | – |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | -$2.37M | -209.1% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | -$2.01M | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$2.09M | – |
| Q1 FY2019CQ2 2018 | Dec 31, 2018 | -$6.77M | – |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $2.17M | – |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | -$2.79M | – |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | -$2.10M | – |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | -$1.45M | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | -$2.30M | – |
| Q4 FY2014CQ3 2014 | Aug 31, 2014 | -$21.08K | – |
| Q3 FY2014CQ2 2014 | May 31, 2014 | -$28.14K | – |
See a number that looks wrong?